Perjeta Injection

As low as $8,611.31
In stock
Only %1 left

SKU
CMS8522
Availability: IN STOCK SKU: CMS8522
Perjeta injection contains Pertuzumab for HER2-positive Breast Cancer treatment. This targeted monoclonal antibody therapy improves survival outcomes.
Pack Size Qty Price Unit Price
1 Injection
$8,611.31
$8,611.31
2 Injection
$16,361.49
$8,180.75
3 Injection
$23,250.54
$7,750.18



What is Perjeta injection

Perjeta injection represents a breakthrough targeted therapy for HER2-positive Breast Cancer. Pertuzumab is an active pharmaceutical ingredient at a 30 mg/ml concentration. Roche Products India Pvt Ltd markets this biological medicine.

This monoclonal antibody specifically targets HER2 protein overexpression. The injection effectively blocks cancer cell growth signals. Pertuzumab prevents HER2 dimerization, stopping tumor progression. Combined with other treatments, it enhances therapeutic outcomes significantly.

Medical oncologists administer this intravenous therapy in specialized cancer centers. Treatment requires careful patient selection based on HER2 testing results. The medication works best in early-stage and metastatic settings.

Common reactions include diarrhea, hair loss, and infusion-related symptoms. Heart function monitoring remains crucial throughout treatment. Blood count supervision ensures patient safety during therapy. Healthcare providers manage side effects through supportive care measures.

Proper refrigeration of unopened vials maintains drug stability and effectiveness. Trained personnel handle preparation and administration procedures. Treatment cycles follow specific protocols for optimal results.

What are the benefits of Perjeta injection

Perjeta injection delivers targeted HER2 blockade through dual pathway inhibition. Pertuzumab binds to different HER2 sites than Trastuzumab. This combination approach maximizes cancer cell destruction while preserving healthy tissues.

Key therapeutic advantages include:

  • Improved survival rates in metastatic Breast Cancer patients.
  • Enhanced pathological complete response in neoadjuvant (therapy before primary treatment) settings.
  • Reduced recurrence risk when combined with chemotherapy.
  • Precise targeting minimizes unnecessary toxicity to normal cells.

Clinical trials demonstrate superior outcomes compared to standard therapy alone. The drug works synergistically with Trastuzumab and chemotherapy regimens. Neoadjuvant treatment helps shrink tumors before surgical intervention.

Early-stage patients experience reduced long-term recurrence rates. Metastatic disease (cancer spreading from the original site to other body parts) patients achieve prolonged progression-free survival. Quality of life improvements accompany effective disease control.

How to take Perjeta injection

Perjeta is a prescription medication administered by healthcare professionals only. Treatment guidelines include:

  • Receive infusions at certified cancer treatment facilities. The initial dose requires slower administration and monitoring.
  • Subsequent cycles typically take shorter infusion times.
  • Pre-medications reduce infusion reaction risks. Regular heart function assessments ensure treatment safety.
  • Do not self-administer.

Strengths and substitutes

Currently, no strengths and substitutes are available at Cheap Medicine Shop.

What are the side effects of Perjeta injection

Perjeta is generally well-tolerated under medical supervision. Potential side effects include:

  • Diarrhea
  • Digestive upset
  • Hair thinning or loss
  • Fatigue
  • Weakness
  • Infusion-related reactions

These effects are typically manageable with appropriate supportive care measures and monitoring.

Safety Advice

Liver disease

The liver function requires monitoring during Perjeta treatment due to potential hepatotoxicity risks. Patients with pre-existing liver conditions need frequent assessments. Always consult a doctor before use.

Kidney impairment

It is generally safe. However, renal function monitoring helps detect treatment-related kidney problems early. Do not use it without medical consultation.

Pregnant and breastfeeding women

Perjeta causes severe fetal harm and birth defects, making pregnancy an absolute contraindication. Women must use effective contraception during treatment and for 7 months afterward. Breastfeeding should be discontinued before starting therapy.

Avoid

Avoid live vaccines during the treatment period. Alcohol consumption should be moderated due to potential liver effects. Inform doctors about all medications, including over-the-counter supplements, before treatment.

FAQs

How is HER2 status determined before Perjeta injection treatment?

HER2 testing uses immunohistochemistry or fluorescence in situ hybridization methods on tumor tissue samples. Results must show HER2 overexpression or gene amplification. This targeted therapy approach benefits only HER2-positive patients.

What heart monitoring is required during Perjeta injection therapy?

Echocardiograms or MUGA scans assess heart function before and during therapy every three months. Left ventricular ejection fraction (the blood pumped out to the body with each heartbeat) must remain above specific thresholds. Treatment stops if significant heart function decline occurs.

Can Perjeta injection be given with other Breast Cancer treatments?

Perjeta combines effectively with Trastuzumab and chemotherapy regimens in standard protocols. Drug interactions require an oncologist's evaluation before adding new medications. Treatment sequencing follows established guidelines for optimal safety and effectiveness.

How long does each Perjeta injection infusion session take?

Initial infusion requires approximately 60 minutes with close monitoring for reactions. Subsequent treatments typically take 30-60 minutes, depending on tolerance. Pre-medication may extend the total appointment time for patient safety.

What should patients expect during Perjeta injection recovery periods?

Most patients tolerate treatment well, with manageable side effects between cycles. Fatigue may persist for several days after infusion. Maintaining nutrition and hydration helps optimize recovery and treatment tolerance.

No reviews yet ... Have an opinion? Help others decide. Share your knowledge about this product by submitting a review.
    What's this? Check "Remember Me" to access your shopping cart on this computer even if you are not signed in.